CCND2 encodes a G1 cyclin that is subject to activating mutations, translocations, and transcriptional upregulation in hematologic malignancies [47, 48], supporting its role as a potential effector of IKAROS-mediated enhancer repression. Here, CCNG1 is linked to hematologic disorder.